The Afrikan Embassy Community Outreach Society Our Services:
Several nonprofit organizations are collecting unused aids and other different medicines not including controlled substances like narcotics) for free distribution abroad to people who otherwise could not afford them. The afrikan embassy is working with some organizations in the USA, Canada, The United Kingdom and The Netherlands as partners to help the unification of Africa These companies are already helping Africa a lot, to help control the spread of aids and various other diseases a gesture that is very well appreciated. Our Community outreach involves quite a lot in respect of these companies their generosity and the help of the human race. Education is one of our top priorities helping people in the Diaspora and abroad. Africans, working through the embassy will have a chance to participate in business, sports, education, and entertainment.

GLOBAL COMMITMENTS

• In 2007, GlaxoSmithKline donated more than $564 million to charitable initiatives in the global community. This equates to 3.8 per cent of our global pre-tax profits and places us among the leaders in charitable giving.
• GlaxoSmithKline has long been active in the struggle for improved health care in the developing world through several innovative, long-term programs.
• Internationally, GSK is the only pharmaceutical company conducting research and development into both the prevention and treatment of all three of the World Health Organization’s (WHO) priority diseases — HIV/AIDS, malaria and tuberculosis.

• In 2007, 150 million albendazole tablets, a preventative drug for the disfiguring tropical disease lymphatic filariasis (or elephantiasis), were donated to help eliminate the disease. Since 1992, approximately 750 million tablets have been donated, reaching over 130 million people.
• GlaxoSmithKline’s Africa Malaria Partnership supports three programs in eight African countries to reduce the impact of malaria through better prevention and treatment in partnership with Freedom from Hunger, AMREF (African Medical and Research Foundation) and Plan International.

• Positive Action, GlaxoSmithKline’s long-term international program of HIV education and care, supports 43 international programs in 36 countries for people living with HIV/AIDS.

For further information, please contact:
Community Partnerships and Philanthropy
                                             The Afrikan Embassy  P.O box 9657 Lowell MA 031853
                                              www.afrikanembassy.com  go to contacy us……..

If you or an organization that you know can help with this project by contributing medicines, supplies or use medical equipment as well as donating money or services or fundraising in a ‘buddy’ supply program, we urge you to cantact us at the above address.
We accept any kind of donations in medical supplies and tranportaion for the people of Africa the Idea is to unite Africa in every way we can Among the most needed medications the following antiretrovirals(all types); anti-tuberculosis medications rifampin, ethambutol, pyrazinamide,anti microbials trimethoprim/ Sulfamethoxazole[Bactrim], pyrimethamine, sulfadiazine folic acid, ceftnaxone antifungals (amphotericin B, Fluconozole, itraconazolei . However any kind of medicine will be well appreciated Africa is in need of anything medical.

CORPORATE SOCIAL RESPONSIBILITY

• GlaxoSmithKline is a leading contributor to Health Partners International of Canada (HPIC). HPIC is a charitable organization that provides free medications, medical supplies and vaccines, donated by Canada’s health industry, including research-based pharmaceutical companies, to Canadian doctors and Non-Governmental Organizations working in the developing world and to countries that are in need of medical aid. Since 1994, GlaxoSmithKline has contributed almost $23 million in humanitarian product donations.
• The GlaxoSmithKline Foundation supports employees who are personally committed to improving their communities by matching employee donations and/or providing a grant to charitable organizations where employees volunteer their time.
• Through the Community Innovation Program (in partnership with Shire BioChem), GlaxoSmithKline annually supports various HIV/AIDS community-based organizations that provide outreach and address barriers to treatment, thereby improving access to care for people living with HIV/AIDS across the country.
• GlaxoSmithKline and its employees provide more than $250,000 annually to United Way/Centraide campaigns in support of local community efforts.
• The GlaxoSmithKline Foundation also provides funding to organizations that encourage the interest and participation of young Canadians in science education, including:

~    ACTUA, a national organization that reaches more than 225,000 youth through interactive science camps, in-school programs and mentoring programs; and.

~    Canadian Biology Olympiad, a training and coaching program designed to help Canadian science students to progress to international competition.

COMMUNITY INVESTMENTS

• GSK is committed to working with patient groups at the highest levels of transparency and ethical standards.
• Community partners include: United Way and Centraide, Canadian Hospice Palliative Care Association, Asthma Society of Canada, Canadian Diabetes Association, Canadian Lung Association, Canadian Breast Cancer Network, National Ovarian Cancer Association and Lymphoma Foundation Canada.  

Comment:
Everyone knows that there will never be enough discarded medications to provide access to morden medical care to 90 percent of the world’s peoplle who do not have it now. But these projects can help many people and also provide a practical way to take the first steps to focusing on the problem.
Clearly there will not be a single answer to medical care in developing world. But there are many approaches  that make sence now. The most important medications are usually in expensive, because they are old drugs which are no longer  patented. Some proprietary drugs are manufactured without permission in developing countries, although under effective health measures are not drugs at all, but clean water and improved nutrition. And in some cases it may be most effective to support or finance the scientific testing and development of in expensive treatments, including traditional remedies. One area that needs more attention is institutional obstacles to negotiating lower prices for government health programs that can not afford US/European rates. Unfortunately some companies are setting global prices – ruling out 90% of the pontetial users of their drugs apparantly because they fear development of a black market. But this risk is institutionalize a black-market supply.